| Literature DB >> 27437079 |
Eric Scocchera1, Stephanie M Reeve1, Santosh Keshipeddy1, Michael N Lombardo1, Behnoush Hajian1, Adrienne E Sochia2, Jeremy B Alverson2, Nigel D Priestley2, Amy C Anderson1, Dennis L Wright1.
Abstract
Although classical, negatively charged antifolates such as methotrexate possess high affinity for the dihydrofolate reductase (DHFR) enzyme, they are unable to penetrate the bacterial cell wall, rendering them poor antibacterial agents. Herein, we report a new class of charged propargyl-linked antifolates that capture some of the key contacts common to the classical antifolates while maintaining the ability to passively diffuse across the bacterial cell wall. Eight synthesized compounds exhibit extraordinary potency against Gram-positive S. aureus with limited toxicity against mammalian cells and good metabolic profile. High resolution crystal structures of two of the compounds reveal extensive interactions between the carboxylate and active site residues through a highly organized water network.Entities:
Keywords: Dihydrofolate reductase; Escherichia coli; MRSA; Staphylococcus aureus; antifolate; methotrexate; trimethoprim
Year: 2016 PMID: 27437079 PMCID: PMC4948012 DOI: 10.1021/acsmedchemlett.6b00120
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345